Advertisement

Overview of the Immune System and Its Pharmacological Targets

  • Clinton B. MathiasEmail author
Chapter

Abstract

The immune system plays a vital role in maintaining the balance between health and disease. Immune cells provide protection against various pathogenic organisms, protecting the host from infection and injury to health. This protection is essential for the survival of the host and contributes to the overall health and longevity of individuals. In contrast, dysregulation of the immune system, resulting in overactive immune responses or autoimmunity are detrimental to the host, and induce tissue damage and development of disease. Chronic inflammation is associated with a number of diseases such as allergy, asthma, inflammatory bowel disease, rheumatoid arthritis, and cancer. This chapter will provide a general overview of the immune system and the principles of the innate and adaptive immune responses. The various cells and molecules of the innate and adaptive immune systems will be discussed and their role in immunity will be examined. In the second half of the chapter, we will examine pharmacological approaches to treating inflammation, and will discuss the various classes of drugs that target immune cells and their mediators. These include drugs that cause immunosuppression, those that prevent the proliferation of immune cells, and those that modulate immune activity. The suggested reading list at the end of the chapter highlights major discoveries in the field of immunology during the last two centuries that have advanced our current understanding of immunology and medicine.

Keywords

Immune Inflammation Innate Adaptive cytokine Interleukin Primary immune responses Secondary immune responses Immune memory T cell activation B cell activation Antibodies Glucocorticoids Anti-proliferative agents Calcineurin inhibitors Biologics 

Suggested Reading1

  1. Jenner E. An inquiry into the causes and effects of variolae vaccinae: a disease discovered in some Western Counties of England. London: Sampson Low; 1798. p. 75.Google Scholar
  2. Jenner E. Letter addressed to the medical profession generally, relative to vaccination. Lond Med Phys J. 1821;45:277–80.PubMedPubMedCentralGoogle Scholar
  3. Pasteur L. Sur les maladies virulentes, et en particulier sur la maladie appelee vulgairement cholera des poules. C R Acad Sci. 1880;90:248–9.Google Scholar
  4. Pasteur LC, Roux E. Compte rendu sommaire des experiences faites a Pouilly-Le-Fort, pres de Melun, sur la vaccination charnonneuse. C R Acad Sci. 1881;92:1378–83.Google Scholar
  5. Koch R. A further communication on a remedy for tuberculosis. Br Med J. 1891;1:125–7.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Koch R. An address on the fight against tuberculosis in the light of the experience that has been gained in the successful combat of other infectious diseases. Br Med J. 1901;2:189–93.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Weil R. Studies in anaphylaxis. XIV. On the relation between precipitin and sensitizin. J Immunol. 1916;1:1–18.Google Scholar
  8. Lurie MB. A correlation between the histological changes and the fate of living tubercule bacilli in the organs of infected rabbits. J Exp Med. 1933;57:31–54.CrossRefGoogle Scholar
  9. Gibson T, Medawar PB. The fate of skin homografts in man. J Anat. 1943;77:299–310 294.PubMedPubMedCentralGoogle Scholar
  10. Chase MW. The cellular transfer of cutaneous sensitivity to tuberculin. Proc Soc Exp Biol Med. 1945;59:134.CrossRefGoogle Scholar
  11. Coombs RR, Mourant AE, Race RR. A new test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol. 1945;26:255–66.PubMedPubMedCentralGoogle Scholar
  12. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science. 1945;102:400–1.PubMedCrossRefGoogle Scholar
  13. Fagraeus A. Plasma cellular reaction and its relation to the formation of antibodies in vitro. Nature. 1947;159:499.PubMedCrossRefGoogle Scholar
  14. Fagraeus A. The plasma cellular reaction and its relation to the formation of antibodies in vitro. J Immunol. 1948;58:1–13.PubMedGoogle Scholar
  15. Snell GD. Methods for the study of histocompatibility genes. J Genet. 1948;49:87–108.PubMedCrossRefGoogle Scholar
  16. Bordley JE, Carey RA, et al. Preliminary observations on the effect of adrenocorticotropic hormone in allergic diseases. Bull Johns Hopkins Hosp. 1949;85:396–8.PubMedGoogle Scholar
  17. Hench PS, Kendall EC, Slocumb CH, Polley HF. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Intern Med (Chic). 1950;85:545–666.CrossRefGoogle Scholar
  18. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172:603–6.PubMedCrossRefGoogle Scholar
  19. Jerne NK. The natural-selection theory of antibody formation. Proc Natl Acad Sci U S A. 1955;41:849–57.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Billingham RE, Brent L, Medawar PB. The antigenic stimulus in transplantation immunity. Nature. 1956;178:514–9.PubMedCrossRefGoogle Scholar
  21. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957;147:258–67.PubMedCrossRefGoogle Scholar
  22. Isaacs A, Lindenmann J, Valentine RC. Virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci. 1957;147:268–73.PubMedCrossRefGoogle Scholar
  23. Nossal GJ, Lederberg J. Antibody production by single cells. Nature. 1958;181:1419–20.PubMedCrossRefGoogle Scholar
  24. Porter RR. Separation and isolation of fractions of rabbit gamma-globulin containing the antibody and antigenic combining sites. Nature. 1958;182:670–1.PubMedCrossRefGoogle Scholar
  25. Burnet FM. The clonal selection theory of acquired immunity. Cambridge: Cambridge University Press; 1959.CrossRefGoogle Scholar
  26. Nowell PC. Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. Cancer Res. 1960;20:462–6.PubMedGoogle Scholar
  27. Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960;39:1157–75.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Dresser DW. Effectiveness of lipid and lipidophilic substances as adjuvants. Nature. 1961;191:1169–71.PubMedCrossRefGoogle Scholar
  29. Burnet FM. The immunological significance of the thymus: an extension of the clonal selection theory of immunity. Australas Ann Med. 1962;11:79–91.PubMedCrossRefGoogle Scholar
  30. Dresser DW. Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology. 1962;5:378–88.PubMedPubMedCentralGoogle Scholar
  31. Mackaness GB. Cellular resistance to infection. J Exp Med. 1962;116:381–406.PubMedPubMedCentralCrossRefGoogle Scholar
  32. Mackaness GB. The immunological basis of acquired cellular resistance. J Exp Med. 1964;120:105–20.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Cooper MD, Peterson RD, Good RA. Delineation of the thymic and bursal lymphoid systems in the chicken. Nature. 1965;205:143–6.PubMedCrossRefGoogle Scholar
  34. Brenner S, Milstein C. Origin of antibody variation. Nature. 1966;211:242–3.PubMedCrossRefGoogle Scholar
  35. Cooper MD, Raymond DA, Peterson RD, South MA, Good RA. The functions of the thymus system and the bursa system in the chicken. J Exp Med. 1966;123:75–102.PubMedPubMedCentralCrossRefGoogle Scholar
  36. Ishizaka K, Ishizaka T. Physicochemical properties of reaginic antibody. 1. Association of reaginic activity with an immunoglobulin other than gammaA- or gammaG-globulin. J Allergy. 1966a;37:169–85.PubMedCrossRefGoogle Scholar
  37. Ishizaka K, Ishizaka T. Physicochemical properties of reaginic antibody. 3. Further studies on the reaginic antibody in gamma-A-globulin preparations. J Allergy. 1966b;38:108–19.PubMedCrossRefGoogle Scholar
  38. Ishizaka K, Ishizaka T, Lee EH. Physiochemical properties of reaginic antibody. II. Characteristic properties of reaginic antibody different from human gamma-A-isohemagglutinin and gamma-D-globulin. J Allergy. 1966a;37:336–49.PubMedCrossRefGoogle Scholar
  39. Ishizaka K, Ishizaka T, Hornbrook MM. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol. 1966b;97:75–85.PubMedGoogle Scholar
  40. Ishizaka K, Ishizaka T, Hornbrook MM. Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol. 1966c;97:840–53.PubMedGoogle Scholar
  41. Edelman GM, Gally JA. Somatic recombination of duplicated genes: an hypothesis on the origin of antibody diversity. Proc Natl Acad Sci U S A. 1967;57:353–8.PubMedPubMedCentralCrossRefGoogle Scholar
  42. Henney CS, Ishizaka K. An antigenic determinant of human gamma-globulin susceptible to papain digestion. J Immunol. 1967;99:695–702.PubMedGoogle Scholar
  43. Ishizaka K, Ishizaka T. Identification of gamma-E-antibodies as a carrier of reaginic activity. J Immunol. 1967;99:1187–98.PubMedGoogle Scholar
  44. Ishizaka K, Ishizaka T, Menzel AE. Physicochemical properties of reaginic antibody. VI. Effect of heat on gamma-E-, gamma-G- and gamma-A-antibodies in the sera of ragweed sensitive patients. J Immunol. 1967a;99:610–8.PubMedGoogle Scholar
  45. Ishizaka K, Ishizaka T, Terry WD. Antigenic structure of gamma-E-globulin and reaginic antibody. J Immunol. 1967b;99:849–58.PubMedGoogle Scholar
  46. Johansson SG, Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology. 1967;13:381–94.PubMedPubMedCentralGoogle Scholar
  47. Mintz B, Silvers WK. “Intrinsic” immunological tolerance in allophenic mice. Science. 1967;158:1484–6.PubMedCrossRefGoogle Scholar
  48. Mishell RI, Dutton RW. Immunization of dissociated spleen cell cultures from normal mice. J Exp Med. 1967;126:423–42.PubMedPubMedCentralCrossRefGoogle Scholar
  49. Edelman GM, et al. The covalent structure of an entire gammaG immunoglobulin molecule. Proc Natl Acad Sci U S A. 1969;63:78–85.PubMedPubMedCentralCrossRefGoogle Scholar
  50. Klinman NR. Antibody with homogeneous antigen binding produced by splenic foci in organ culture. Immunochemistry. 1969;6:757–9.PubMedCrossRefGoogle Scholar
  51. McDevitt HO, Chinitz A. Genetic control of the antibody response: relationship between immune response and histocompatibility (H-2) type. Science. 1969;163:1207–8.PubMedCrossRefGoogle Scholar
  52. Raff MC. Two distinct populations of peripheral lymphocytes in mice distinguishable by immunofluorescence. Immunology. 1970;19:637–50.PubMedPubMedCentralGoogle Scholar
  53. Wu TT, Kabat EA. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med. 1970;132:211–50.PubMedPubMedCentralCrossRefGoogle Scholar
  54. Armstrong JA, D’Arcy Hart P. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med. 1971;134:713–40.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Craig SW, Cebra JJ. Peyer’s patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med. 1971;134:188–200.PubMedPubMedCentralCrossRefGoogle Scholar
  56. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med. 1971a;134:83–102.PubMedPubMedCentralCrossRefGoogle Scholar
  57. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J Exp Med. 1971b;134:1513–28.PubMedPubMedCentralCrossRefGoogle Scholar
  58. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 1971;8:871–4.PubMedCrossRefGoogle Scholar
  59. Jerne NK. The somatic generation of immune recognition. Eur J Immunol. 1971;1:1–9.PubMedCrossRefGoogle Scholar
  60. Mitchison NA. The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis. Eur J Immunol. 1971a;1:10–7.PubMedCrossRefGoogle Scholar
  61. Mitchison NA. The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Eur J Immunol. 1971b;1:18–27.PubMedCrossRefGoogle Scholar
  62. Sprent J, Miller JF, Mitchell GF. Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol. 1971;2:171–81.PubMedCrossRefGoogle Scholar
  63. Klinman NR. The mechanism of antigenic stimulation of primary and secondary clonal precursor cells. J Exp Med. 1972;136:241–60.PubMedPubMedCentralCrossRefGoogle Scholar
  64. Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest. 1973;52:741–4.PubMedPubMedCentralCrossRefGoogle Scholar
  65. Cotton RG, Milstein C. Letter: fusion of two immunoglobulin-producing myeloma cells. Nature. 1973;244:42–3.PubMedCrossRefGoogle Scholar
  66. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 1973;137:1142–62.PubMedPubMedCentralCrossRefGoogle Scholar
  67. Strander H, Cantell K, Carlstrom G, Jakobsson PA. Clinical and laboratory investigations on man: systemic administration of potent interferon to man. J Natl Cancer Inst. 1973;51:733–42.PubMedCrossRefGoogle Scholar
  68. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974;2:1279–83.PubMedCrossRefGoogle Scholar
  69. Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components: differential localization of free and bound SC in secretory epithelial cells. J Immunol. 1974;112:1553–9.PubMedGoogle Scholar
  70. MacCuish AC, Irvine WJ, Barnes EW, Duncan LJ. Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet. 1974;2:1529–31.PubMedCrossRefGoogle Scholar
  71. Owen JJ, Cooper MD, Raff MC. In vitro generation of B lymphocytes in mouse foetal liver, a mammalian ‘bursa equivalent’. Nature. 1974;249:361–3.PubMedCrossRefGoogle Scholar
  72. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med. 1974;139:380–97.PubMedPubMedCentralCrossRefGoogle Scholar
  73. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 1974;248:701–2.PubMedCrossRefGoogle Scholar
  74. Bevan MJ. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med. 1975;142:1349–64.PubMedCrossRefGoogle Scholar
  75. Cantor H, Boyse EA. Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med. 1975a;141:1376–89.PubMedCrossRefGoogle Scholar
  76. Cantor H, Boyse EA. Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J Exp Med. 1975b;141:1390–9.PubMedCrossRefGoogle Scholar
  77. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495–7.PubMedPubMedCentralCrossRefGoogle Scholar
  78. Burnet FM. A modification of Jerne’s theory of antibody production using the concept of clonal selection. CA Cancer J Clin. 1976;26:119–21.PubMedCrossRefGoogle Scholar
  79. Hozumi N, Tonegawa S. Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc Natl Acad Sci U S A. 1976;73:3628–32.PubMedPubMedCentralCrossRefGoogle Scholar
  80. Solley GO, Gleich GJ, Jordon RE, Schroeter AL. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest. 1976;58:408–20.PubMedPubMedCentralCrossRefGoogle Scholar
  81. Robinson JH, Owen JJ. Generation of T-cell function in organ culture of foetal mouse thymus. II. Mixed lymphocyte culture reactivity. Clin Exp Immunol. 1977;27:322–7.PubMedPubMedCentralGoogle Scholar
  82. Ruscetti FW, Morgan DA, Gallo RC. Functional and morphologic characterization of human T cells continuously grown in vitro. J Immunol. 1977;119:131–8.PubMedGoogle Scholar
  83. Silverton EW, Navia MA, Davies DR. Three-dimensional structure of an intact human immunoglobulin. Proc Natl Acad Sci U S A. 1977;74:5140–4.PubMedPubMedCentralCrossRefGoogle Scholar
  84. Brack C, Hirama M, Lenhard-Schuller R, Tonegawa S. A complete immunoglobulin gene is created by somatic recombination. Cell. 1978;15:1–14.PubMedCrossRefGoogle Scholar
  85. Baker PE, Gillis S, Smith KA. Monoclonal cytolytic T-cell lines. J Exp Med. 1979;149:273–8.PubMedCrossRefGoogle Scholar
  86. Kung P, Goldstein G, Reinherz EL, Schlossman SF. Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979;206:347–9.PubMedCrossRefGoogle Scholar
  87. Murphy RC, Hammarstrom S, Samuelsson B. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci U S A. 1979;76:4275–9.PubMedPubMedCentralCrossRefGoogle Scholar
  88. Parks DR, Bryan VM, Oi VT, Herzenberg LA. Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc Natl Acad Sci U S A. 1979;76:1962–6.PubMedPubMedCentralCrossRefGoogle Scholar
  89. Reinherz EL, Kung PC, Goldstein G, Schlossman SF. Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci U S A. 1979;76:4061–5.PubMedPubMedCentralCrossRefGoogle Scholar
  90. Silverstein AM. History of immunology. Cell Immunol. 1979a;42:1–2.PubMedCrossRefGoogle Scholar
  91. Silverstein AM. History of immunology. Cellular versus humoral immunity: determinants and consequences of an epic 19th century battle. Cell Immunol. 1979b;48:208–21.PubMedCrossRefGoogle Scholar
  92. Davis MM, et al. An immunoglobulin heavy-chain gene is formed by at least two recombinational events. Nature. 1980;283:733–9.PubMedCrossRefGoogle Scholar
  93. Early P, Huang H, Davis M, Calame K, Hood L. An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell. 1980;19:981–92.PubMedCrossRefGoogle Scholar
  94. Silverstein AM, Bialasiewicz AA. History of immunology. A history of theories of acquired immunity. Cell Immunol. 1980;51:151–67.PubMedCrossRefGoogle Scholar
  95. Van Wauwe JP, De Mey JR, Goossens JG. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J Immunol. 1980;124:2708–13.PubMedGoogle Scholar
  96. Kappler JW, Skidmore B, White J, Marrack P. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med. 1981;153:1198–214.PubMedPubMedCentralCrossRefGoogle Scholar
  97. Silverstein AM, Miller G. History of immunology. The royal experiment on immunity: 1721-1722. Cell Immunol. 1981;61:437–47.PubMedCrossRefGoogle Scholar
  98. Steiner H, Hultmark D, Engstrom A, Bennich H, Boman HG. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature. 1981;292:246–8.CrossRefGoogle Scholar
  99. Ziegler K, Unanue ER. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J Immunol. 1981;127:1869–75.PubMedGoogle Scholar
  100. Allison JP, McIntyre BW, Bloch D. Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. J Immunol. 1982;129:2293–300.PubMedGoogle Scholar
  101. Butcher EC, et al. Surface phenotype of Peyer’s patch germinal center cells: implications for the role of germinal centers in B cell differentiation. J Immunol. 1982;129:2698–707.PubMedGoogle Scholar
  102. Howard M, et al. Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med. 1982;155:914–23.PubMedPubMedCentralCrossRefGoogle Scholar
  103. Isakson PC, Pure E, Vitetta ES, Krammer PH. T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J Exp Med. 1982;155:734–48.PubMedPubMedCentralCrossRefGoogle Scholar
  104. Silverstein AM. History of immunology. Development of the concept of immunologic specificity, I. Cell Immunol. 1982a;67:396–409.PubMedCrossRefGoogle Scholar
  105. Silverstein AM. History of immunology: development of the concept of immunologic specificity: II. Cell Immunol. 1982b;71:183–95.PubMedCrossRefGoogle Scholar
  106. Takahashi N, et al. Structure of human immunoglobulin gamma genes: implications for evolution of a gene family. Cell. 1982;29:671–9.PubMedCrossRefGoogle Scholar
  107. Turkeltaub PC, Rastogi SC, Baer H, Anderson MC, Norman PS. A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results. J Allergy Clin Immunol. 1982;70:343–52.PubMedCrossRefGoogle Scholar
  108. Haskins K, et al. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J Exp Med. 1983;157:1149–69.PubMedCrossRefGoogle Scholar
  109. Kappler J, et al. The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides. Cell. 1983;35:295–302.CrossRefGoogle Scholar
  110. Tonegawa S. Somatic generation of antibody diversity. Nature. 1983;302:575–81.PubMedCrossRefGoogle Scholar
  111. Auron PE, et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci U S A. 1984;81:7907–11.PubMedPubMedCentralCrossRefGoogle Scholar
  112. Gough NM, et al. Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor. Nature. 1984;309:763–7.PubMedCrossRefGoogle Scholar
  113. Hedrick SM, Cohen DI, Nielsen EA, Davis MM. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature. 1984;308:149–53.PubMedCrossRefGoogle Scholar
  114. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–5.PubMedCrossRefGoogle Scholar
  115. McKean D, et al. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1984;81:3180–4.PubMedPubMedCentralCrossRefGoogle Scholar
  116. Morrison SL, Johnson MJ, Herzenberg LA, Oi VT. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A. 1984;81:6851–5.PubMedPubMedCentralCrossRefGoogle Scholar
  117. Rock KL, Benacerraf B, Abbas AK. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med. 1984;160:1102–13.PubMedCrossRefGoogle Scholar
  118. Townsend AR, McMichael AJ, Carter NP, Huddleston JA, Brownlee GG. Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell. 1984;39:13–25.PubMedCrossRefGoogle Scholar
  119. Babbitt BP, Allen PM, Matsueda G, Haber E, Unanue ER. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature. 1985;317:359–61.PubMedCrossRefGoogle Scholar
  120. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985;229:869–71.PubMedCrossRefGoogle Scholar
  121. Jenner E, Pasteur L. [From Jenner to Pasteur or the development of ideas on vaccination]. Bull Acad Natl Med. 1985;169:771–8.Google Scholar
  122. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 1985;314:537–9.PubMedCrossRefGoogle Scholar
  123. Nakano T, et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med. 1985;162:1025–43.PubMedCrossRefGoogle Scholar
  124. Brenner MB, et al. Identification of a putative second T-cell receptor. Nature. 1986;322:145–9.PubMedCrossRefGoogle Scholar
  125. Clark EA, Ledbetter JA. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci U S A. 1986;83:4494–8.PubMedPubMedCentralCrossRefGoogle Scholar
  126. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986;137:245–54.PubMedGoogle Scholar
  127. Jones PT, Dear PH, Foote J, Neuberger MS, Winter G. Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature. 1986;321:522–5.CrossRefGoogle Scholar
  128. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 1986;319:675–8.PubMedCrossRefGoogle Scholar
  129. Kehrl JH, et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986;163:1037–50.PubMedCrossRefGoogle Scholar
  130. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348–57.Google Scholar
  131. Rothlein R, Dustin ML, Marlin SD, Springer TA. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol. 1986;137:1270–4.PubMedGoogle Scholar
  132. Royer-Pokora B, et al. Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal location. Nature. 1986;322:32–8.PubMedCrossRefGoogle Scholar
  133. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 1986a;47:921–8.PubMedCrossRefGoogle Scholar
  134. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986b;46:705–16.PubMedCrossRefGoogle Scholar
  135. Bjorkman PJ, et al. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987a;329:506–12.CrossRefGoogle Scholar
  136. Bjorkman PJ, et al. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature. 1987b;329:512–8.PubMedCrossRefGoogle Scholar
  137. Brunet JF, et al. A new member of the immunoglobulin superfamily—CTLA-4. Nature. 1987;328:267–70.PubMedCrossRefGoogle Scholar
  138. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol. 1987;138:3688–94.PubMedGoogle Scholar
  139. Doyle C, Strominger JL. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature. 1987;330:256–9.PubMedCrossRefGoogle Scholar
  140. Jenkins MK, Schwartz RH. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med. 1987;165:302–19.PubMedCrossRefGoogle Scholar
  141. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 1987;49:273–80.PubMedCrossRefGoogle Scholar
  142. Orme IM. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol. 1987;138:293–8.PubMedGoogle Scholar
  143. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 1987;236:944–7.PubMedCrossRefGoogle Scholar
  144. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J Immunol. 1987a;139:788–93.PubMedGoogle Scholar
  145. Yoshimura T, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A. 1987b;84:9233–7.PubMedPubMedCentralCrossRefGoogle Scholar
  146. Bird RE, et al. Single-chain antigen-binding proteins. Science. 1988;242:423–6.PubMedCrossRefGoogle Scholar
  147. Goodnow CC, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 1988;334:676–82.PubMedCrossRefGoogle Scholar
  148. Schall TJ, et al. A human T cell-specific molecule is a member of a new gene family. J Immunol. 1988;141:1018–25.PubMedGoogle Scholar
  149. Shaw JP, et al. Identification of a putative regulator of early T cell activation genes. Science. 1988;241:202–5.PubMedCrossRefGoogle Scholar
  150. Coffman RL, Lebman DA, Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med. 1989;170:1039–44.PubMedCrossRefGoogle Scholar
  151. Emmel EA, et al. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science. 1989;246:1617–20.PubMedCrossRefGoogle Scholar
  152. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170:2081–95.PubMedCrossRefGoogle Scholar
  153. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 1989;54(Pt 1):1–13.CrossRefGoogle Scholar
  154. Lefrancois L, Goodman T. In vivo modulation of cytolytic activity and Thy-1 expression in TCR-gamma delta+ intraepithelial lymphocytes. Science. 1989;243:1716–8.PubMedCrossRefGoogle Scholar
  155. Porcelli S, et al. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature. 1989;341:447–50.PubMedCrossRefGoogle Scholar
  156. Schatz DG, Oettinger MA, Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell. 1989;59:1035–48.PubMedCrossRefGoogle Scholar
  157. Sonoda E, et al. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med. 1989;170:1415–20.PubMedCrossRefGoogle Scholar
  158. Townsend A, et al. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature. 1989;340:443–8.PubMedCrossRefGoogle Scholar
  159. Wright AE, Douglas SR, Sanderson JB. An experimental investigation of the role of the blood fluids in connection with phagocytosis. 1903. Rev Infect Dis. 1989;11:827–34.PubMedCrossRefGoogle Scholar
  160. Conrad DH, Ben-Sasson SZ, Le Gros G, Finkelman FD, Paul WE. Infection with Nippostrongylus brasiliensis or injection of anti-IgD antibodies markedly enhances Fc-receptor-mediated interleukin 4 production by non-B, non-T cells. J Exp Med. 1990;171:1497–508.PubMedCrossRefGoogle Scholar
  161. Hombach J, Tsubata T, Leclercq L, Stappert H, Reth M. Molecular components of the B-cell antigen receptor complex of the IgM class. Nature. 1990;343:760–2.PubMedCrossRefGoogle Scholar
  162. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science. 1990;248:1227–30.PubMedCrossRefGoogle Scholar
  163. Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med. 1990;172:921–9.PubMedCrossRefGoogle Scholar
  164. Linsley PS, Clark EA, Ledbetter JA. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci U S A. 1990;87:5031–5.PubMedPubMedCentralCrossRefGoogle Scholar
  165. Monaco JJ, Cho S, Attaya M. Transport protein genes in the murine MHC: possible implications for antigen processing. Science. 1990;250:1723–6.PubMedCrossRefGoogle Scholar
  166. Moore KW, et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science. 1990;248:1230–4.PubMedCrossRefGoogle Scholar
  167. Oettinger MA, Schatz DG, Gorka C, Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science. 1990;248:1517–23.PubMedCrossRefGoogle Scholar
  168. Ruddle NH, et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med. 1990;172:1193–200.PubMedCrossRefGoogle Scholar
  169. Zijlstra M, et al. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature. 1990;344:742–6.PubMedCrossRefGoogle Scholar
  170. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 1991;351:290–6.PubMedCrossRefGoogle Scholar
  171. Fiorentino DF, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991;146:3444–51.PubMedGoogle Scholar
  172. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science. 1991;253:1278–80.PubMedCrossRefGoogle Scholar
  173. Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science. 1991;253:1280–3.PubMedCrossRefGoogle Scholar
  174. Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med. 1991;173:159–66.PubMedCrossRefGoogle Scholar
  175. Rudensky A, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr. Sequence analysis of peptides bound to MHC class II molecules. Nature. 1991;353:622–7.PubMedCrossRefGoogle Scholar
  176. Todd JA, et al. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature. 1991;351:542–7.PubMedCrossRefGoogle Scholar
  177. von Behring E, Kitasato S. [The mechanism of diphtheria immunity and tetanus immunity in animals. 1890]. Mol Immunol. 1991;28(1317):1319–20.Google Scholar
  178. Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 1992;256:105–7.PubMedCrossRefGoogle Scholar
  179. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11:3887–95.PubMedPubMedCentralCrossRefGoogle Scholar
  180. Janeway CA Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today. 1992;13:11–6.PubMedCrossRefGoogle Scholar
  181. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature. 1992;358:66–70.PubMedCrossRefGoogle Scholar
  182. Noelle RJ, et al. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A. 1992;89:6550–4.PubMedPubMedCentralCrossRefGoogle Scholar
  183. Schindler C, Shuai K, Prezioso VR, Darnell JE Jr. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science. 1992;257:809–13.CrossRefGoogle Scholar
  184. Velazquez L, Fellous M, Stark GR, Pellegrini S. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell. 1992;70:313–22.PubMedCrossRefGoogle Scholar
  185. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992;356:314–7.PubMedCrossRefGoogle Scholar
  186. Zychlinsky A, Prevost MC, Sansonetti PJ. Shigella flexneri induces apoptosis in infected macrophages. Nature. 1992;358:167–9.PubMedCrossRefPubMedCentralGoogle Scholar
  187. Brown JH, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993;364:33–9.PubMedCrossRefPubMedCentralGoogle Scholar
  188. Gay D, Saunders T, Camper S, Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med. 1993;177:999–1008.PubMedCrossRefPubMedCentralGoogle Scholar
  189. Heinzel FP, Rerko RM, Hatam F, Locksley RM. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J Immunol. 1993;150:3924–31.PubMedPubMedCentralGoogle Scholar
  190. Hsieh CS, et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993;260:547–9.PubMedCrossRefPubMedCentralGoogle Scholar
  191. Noguchi M, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993;73:147–57.PubMedCrossRefGoogle Scholar
  192. Shinkai Y, et al. Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science. 1993;259:822–5.PubMedCrossRefPubMedCentralGoogle Scholar
  193. Tiegs SL, Russell DM, Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med. 1993;177:1009–20.PubMedCrossRefGoogle Scholar
  194. De Togni P, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 1994;264:703–7.PubMedCrossRefGoogle Scholar
  195. Hogquist KA, et al. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17–27.PubMedCrossRefGoogle Scholar
  196. Iwashima M, Irving BA, van Oers NS, Chan AC, Weiss A. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science. 1994;263:1136–9.PubMedCrossRefGoogle Scholar
  197. Jardetzky TS, et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994;368:711–8.PubMedCrossRefGoogle Scholar
  198. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. Cytotoxic T-cell memory without antigen. Nature. 1994;369:648–52.PubMedCrossRefGoogle Scholar
  199. Saint-Ruf C, et al. Analysis and expression of a cloned pre-T cell receptor gene. Science. 1994;266:1208–12.PubMedCrossRefGoogle Scholar
  200. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109–18.PubMedCrossRefGoogle Scholar
  201. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature. 1994;372:100–3.PubMedCrossRefGoogle Scholar
  202. Walunas TL, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1994;1:405–13.PubMedCrossRefGoogle Scholar
  203. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med. 1995;182:459–65.PubMedCrossRefGoogle Scholar
  204. McBlane JF, et al. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell. 1995;83:387–95.PubMedCrossRefGoogle Scholar
  205. Robey E, Allison JP. T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol Today. 1995;16:306–10.PubMedCrossRefGoogle Scholar
  206. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.Google Scholar
  207. Yao Z, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995;3:811–21.PubMedCrossRefGoogle Scholar
  208. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;272:872–7.PubMedCrossRefGoogle Scholar
  209. Garboczi DN, et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 1996;384:134–41.PubMedCrossRefGoogle Scholar
  210. Garcia KC, et al. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science. 1996;274:209–19.PubMedCrossRefGoogle Scholar
  211. Larsen CP, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996;381:434–8.PubMedCrossRefGoogle Scholar
  212. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996;86:973–83.PubMedPubMedCentralCrossRefGoogle Scholar
  213. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394–7.CrossRefGoogle Scholar
  214. Muzio M, Ni J, Feng P, Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 1997;278:1612–5.PubMedCrossRefGoogle Scholar
  215. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 1997;7:837–47.PubMedCrossRefGoogle Scholar
  216. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997;89:587–96.PubMedCrossRefGoogle Scholar
  217. Butz EA, Bevan MJ. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity. 1998;8:167–75.PubMedPubMedCentralCrossRefGoogle Scholar
  218. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 1998;395:82–6.PubMedCrossRefGoogle Scholar
  219. Murali-Krishna K, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 1998;8:177–87.PubMedCrossRefGoogle Scholar
  220. Poltorak A, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085–8.PubMedCrossRefGoogle Scholar
  221. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998;101:273–81.PubMedPubMedCentralCrossRefGoogle Scholar
  222. Bauer S, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285:727–9.PubMedPubMedCentralCrossRefGoogle Scholar
  223. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999;5:1365–9.CrossRefGoogle Scholar
  224. Forster R, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999;99:23–33.PubMedCrossRefGoogle Scholar
  225. Grakoui A, et al. The immunological synapse: a molecular machine controlling T cell activation. Science. 1999;285:221–7.PubMedCrossRefGoogle Scholar
  226. Hoshino K, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999;162:3749–52.PubMedGoogle Scholar
  227. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999;11:141–51.CrossRefGoogle Scholar
  228. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999;401:556–62.PubMedCrossRefGoogle Scholar
  229. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708–12.CrossRefGoogle Scholar
  230. Muramatsu M, et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102:553–63.PubMedCrossRefGoogle Scholar
  231. Szabo SJ, et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100:655–69.PubMedCrossRefGoogle Scholar
  232. Chambers CA, Kuhns MS, Egen JG, Allison JP. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol. 2001;19:565–94.PubMedCrossRefGoogle Scholar
  233. Girardi M, et al. Regulation of cutaneous malignancy by gammadelta T cells. Science. 2001;294:605–9.PubMedCrossRefGoogle Scholar
  234. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001;291:2413–7.CrossRefGoogle Scholar
  235. Shankaran V, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001;410:1107–11.PubMedCrossRefGoogle Scholar
  236. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002;296:1323–6.PubMedCrossRefGoogle Scholar
  237. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–6.CrossRefGoogle Scholar
  238. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.PubMedPubMedCentralCrossRefGoogle Scholar
  239. Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity. 2004;21:401–13.PubMedCrossRefGoogle Scholar
  240. Silverstein AM. Paul Ehrlich, archives and the history of immunology. Nat Immunol. 2005;6:639.PubMedCrossRefGoogle Scholar
  241. Khanna KM, McNamara JT, Lefrancois L. In situ imaging of the endogenous CD8 T cell response to infection. Science. 2007;318:116–20.PubMedPubMedCentralCrossRefGoogle Scholar
  242. Kaufmann SH. Immunology’s foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff. Nat Immunol. 2008a;9:705–12.PubMedCrossRefGoogle Scholar
  243. Kaufmann SH. Paul Ehrlich: founder of chemotherapy. Nat Rev Drug Discov. 2008b;7:373.PubMedCrossRefGoogle Scholar
  244. Robinson JH, Owen JJ. Pillars article: generation of T-cell function in organ culture of foetal mouse thymus I. Mitogen responsiveness. 1975. J Immunol. 2008;181:7437–44.PubMedCrossRefGoogle Scholar
  245. Xu Z, Zan H, Pone EJ, Mai T, Casali P. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol. 2012;12:517–31.PubMedPubMedCentralCrossRefGoogle Scholar
  246. Cooper MD. The early history of B cells. Nat Rev Immunol. 2015;15:191–7.PubMedCrossRefGoogle Scholar
  247. Gitlin AD, Nussenzweig MC. Immunology: fifty years of B lymphocytes. Nature. 2015;517:139–41.PubMedCrossRefGoogle Scholar
  248. Akdis M, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: receptors, functions, and roles in disease. J Allergy Clin Immunol. 2016;138:984–1010.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Pharmaceutical and Administrative SciencesCollege of Pharmacy and Health Sciences, Western New England UniversitySpringfieldUSA

Personalised recommendations